Jeff Swainson - Brickell Biotech CFO
| BBI Stock | USD 0.88 0.03 3.30% |
CFO
Mr. Jeff Swainson was appointed as Chief Financial Officer of Blackbird Energy Inc. with effect from 19 February 2015. Mr. Swainson is a Chartered Accountant with over seven years of broad finance experience in audit financial reporting tax budgeting and forecasting cash management internal controls and strategic analysis. Mr. Swainson began his career with BDO Canada LLP where he conducted audits of both privately held and publicly traded companies in the oil and gas exploration and production and oil and gas services industries. Subsequent to receiving his CA designation Mr. Swainson held positions of increasing responsibility with Chevron Canada Resources and Sonde Resources Corp since 2015.
| Tenure | 9 years |
| Address | 5777 Central Avenue, Boulder, CO, United States, 80301 |
| Phone | 720 505 4755 |
| Web | https://www.brickellbio.com |
Brickell Biotech Management Efficiency
The company has Return on Asset of (0.802) % which means that on every $100 spent on assets, it lost $0.802. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.5729) %, meaning that it generated no profit with money invested by stockholders. Brickell Biotech's management efficiency ratios could be used to measure how well Brickell Biotech manages its routine affairs as well as how well it operates its assets and liabilities. The Brickell Biotech's current Return On Tangible Assets is estimated to increase to -1.45. The Brickell Biotech's current Return On Capital Employed is estimated to increase to -1.73. As of now, Brickell Biotech's Total Current Assets are decreasing as compared to previous years. The Brickell Biotech's current Net Tangible Assets is estimated to increase to about 36.3 M, while Total Assets are projected to decrease to under 32.5 M.Similar Executives
| Found 6 records | CFO Age | ||
| Paul Thomson | Academy Sports OutdoorsInc | N/A | |
| William Nurthen | Aris Water Solutions | 42 | |
| Xia CFA | WEC Energy Group | 54 | |
| Earl IV | Academy Sports OutdoorsInc | 46 | |
| Michael Kennedy | Antero Midstream Partners | 49 | |
| Brendan Kruege | Antero Midstream Partners | N/A | |
Management Performance
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.8 |
Brickell Biotech Leadership Team
Elected by the shareholders, the Brickell Biotech's board of directors comprises two types of representatives: Brickell Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brickell. The board's role is to monitor Brickell Biotech's management team and ensure that shareholders' interests are well served. Brickell Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brickell Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ron Schmitz, CFO, Director | ||
| Rainer Hettmer, Sole Member of the Management Board | ||
| Don Noakes, Vice President - Operations | ||
| Josh Wylie, Vice President - Land | ||
| William Macdonald, President Director | ||
| FranzXaver Schmidbauer, Vice Chairman of the Supervisory Board | ||
| Ludwig Schlosser, Chairman of the Supervisory Board | ||
| Jeff Swainson, CFO | ||
| David JD, G Officer | ||
| Sean Campbell, Director | ||
| Joshua Mann, Vice President - Business Development | ||
| RPh MBA, CoFounder Chairman | ||
| Ralph Allen, Vice President - Geoscience | ||
| MBA MS, Chief Officer | ||
| Petra Riechert, Investor Relations Contact Officer | ||
| Rupert Hackl, Member of the Supervisory Board | ||
| Albert II, CFO Officer | ||
| Andrew Sklawer, President, CoFounder | ||
| Garth Braun, President CEO, Director | ||
| Sue Fattor, Head Resource | ||
| Ulrich Wiehle, Investor Relations Contact | ||
| Craig Wiebe, Vice President - Exploration | ||
| Nancy Seretta, VP Operations | ||
| PM MBA, VP Operations | ||
| Kevin Andrus, Independent Director | ||
| Gary Walker, Chief Officer | ||
| Attorney Brown, CEO Director |
Brickell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brickell Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.8 | ||||
| Operating Margin | (6.58) % | ||||
| Current Valuation | (8.35 M) | ||||
| Shares Outstanding | 2.87 M | ||||
| Shares Owned By Insiders | 1.20 % | ||||
| Shares Owned By Institutions | 13.07 % | ||||
| Number Of Shares Shorted | 189.59 K | ||||
| Price To Earning | (35.16) X | ||||
| Price To Book | 0.41 X |
Pair Trading with Brickell Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Brickell Stock
| 0.61 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
Moving against Brickell Stock
| 0.87 | RZLT | Rezolute Trending | PairCorr |
| 0.76 | INDP | Indaptus Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.75 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.73 | CELC | Celcuity LLC Financial Report 20th of May 2024 | PairCorr |
| 0.72 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.
The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Brickell Stock analysis
When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.42) | Revenue Per Share 1.94 | Quarterly Revenue Growth 27.576 | Return On Assets (0.80) | Return On Equity (1.57) |
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.